Clinical impact of the recurrent genomic imbalances and the number of genomic imbalances in T-ALL. (A) EFS according to the genomic complexity (≥15 genomic imbalances) in the whole cohort of T-ALL (P = .007). (B) CIR according to the genomic complexity (≥15 genomic imbalances) in the whole cohort of T-ALL (P = .003). (C) Forest plot of the univariate Cox regression analysis for EFS and CIR showing the HR for EFS and the SHR for CIR of recurrent genomic imbalances in the whole cohort of patients.
Figure 6.

Clinical impact of the recurrent genomic imbalances and the number of genomic imbalances in T-ALL. (A) EFS according to the genomic complexity (≥15 genomic imbalances) in the whole cohort of T-ALL (P = .007). (B) CIR according to the genomic complexity (≥15 genomic imbalances) in the whole cohort of T-ALL (P = .003). (C) Forest plot of the univariate Cox regression analysis for EFS and CIR showing the HR for EFS and the SHR for CIR of recurrent genomic imbalances in the whole cohort of patients.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal